Skip to content

Clinical trials

Completed Lymphangioleiomyomatosis trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphangioleiomyomatosis Status: Completed Clear all

28 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20021
20051
20062
20071
20093
20101
20111
20121
20131
20142
20164
20171
20183
20192
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed28

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Heart, Lung, and Blood Institute (NHLBI)6
Novartis Pharmaceuticals3
University of Cincinnati3
Brigham and Women's Hospital2
Children's Hospital Medical Center, Cincinnati2
Groupe d'Etudes et de Recherche sur les Maladies Orphelines Pulmonaires1
IRCCS Multimedica1
InCor Heart Institute1
Medical University of South Carolina1
Schön Klinik Berchtesgadener Land1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphangioleiomyomatosis28
Tuberous Sclerosis10
Angiomyolipoma3
Ascites2
Hereditary Sensory and Autonomic Neuropathies2
Lung Diseases2
Lymphangiomyoma2
Acute Lung Injury1
Asthma1
Astrocytoma1

Trials

Showing 1 to 25 of 28. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.